申请人:NEUROSEARCH A/S
公开号:EP0432648A2
公开(公告)日:1991-06-19
A method of treatment with compounds having the formula
wherein
R¹ is hydrogen, C₁₋₆-alkyl which may be branched, C₃₋₇-cycloalkyl, benzyl, phenyl which may be substituted, acyl, hydroxy, C₁₋₆-alkoxy, CH₂CO₂R' wherein R' is hydrogen or C₁₋₆-alkyl which may be branched, CH₂CN, CH₂CONRIVRV wherein RIV and RV independently are hydrogen or C₁₋₆-alkyl, or CH₂C(=NOH)NH₂;
R² is hydrogen, benzyl, C₁₋₆-alkyl which may be branched, or C₃₋₇-cycloalkyl;
R⁴, R⁵, R⁶, R⁷ independently are hydrogen, C₁₋₆-alkyl which may be branched, phenyl, halogen, C₁₋₆-alkoxy, NO₂, CN, SO₂NR''R''' wherein R'' and R''' independently are hydrogen or C₁₋₆-alkyl, or CF₃; or R⁶ and R⁷ together form an additional 4 to 7 membered ring which may be aromatic or partial saturated and which may be substituted with halogen, NO₂, CF₃, CN, SO₂NR''R''' wherein R'' and R''' independently are hydrogen or C₁₋₆-alkyl, and R⁴ and R⁵ have the meanings set forth above, are disclosed, as well as pharmaceutical compositions thereof. Certain of the compounds are novel.
The compounds and pharmaceutical compositions containing the compounds are useful in the treatment of central nervous system disorders and especially conditions sensitive to excitatory amino acids.
一种用具有以下式子的化合物进行处理的方法
其中
R¹ 是氢、C₁₋₆-烷基(可以是支链)、C₃₋₇-环烷基、苄基、苯基(可以是取代的)、酰基、羟基、C₁₋₆-烷氧基、CH₂CO₂R',其中 R' 为氢或 C₁₋₆- 烷基(可为支链)、CH₂CN、CH₂CONRIVRV,其中 RIV 和 RV 独立地为氢或 C₁₋₆- 烷基,或 CH₂C(=NOH)NH₂;
R² 是氢、苄基、C₁₋₆-烷基(可以是支链)或 C₃₋₇-环烷基;
R⁴、R⁵、R⁶、R⁷各自为氢、C₁₋₆-烷基(可为支链)、苯基、卤素、C₁₋₆-烷氧基、NO₂、CN、SO₂NR''R'''(其中 R'' 和 R''' 各自为氢或 C₁₋₆-烷基)或 CF₃;或 R⁶ 和 R⁷ 共同形成另外一个 4 至 7 个成员的环,该环可以是芳香族或部分饱和环,可以被卤素、NO₂、CF₃、CN、公开了 SO₂NR''R''',其中 R'' 和 R''' 独立地为氢或 C₁₋₆ 烷基,且 R⁴ 和 R⁵ 具有上述含义,还公开了其药物组合物。其中某些化合物是新颖的。
这些化合物和含有这些化合物的药物组合物可用于治疗中枢神经系统疾病,特别是对兴奋性氨基酸敏感的疾病。